NewzResearchers at the Hospital del Mar in Barcelona have validated a new liquid biopsy technique that uses blood analysis to detect tumor mutations in patients with biliary tract cancer. The study confirms the reliability of this diagnostic method for identifying specific genetic markers in these tumors.
This advancement facilitates the personalization of medical treatments for biliary tract cancer. By enabling precise identification of mutations through a non-invasive blood test, the technique aims to improve therapeutic decision-making for patients facing this diagnosis.
In-depth summary · AI, neutral